Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05505500 · ClinicalTrials.gov registry record
Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.
A clinical trial of Edema and Fluid Overload, sponsored by University of Michigan.
- Recruiting
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT05505500: Recruiting study of Edema and Fluid Overload, sponsored by University of Michigan.
NCT05505500 is a study of Edema and Fluid Overload that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 150 participants, below the 453-participant average among 13 other Edema trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05505500, a study of Edema and Fluid Overload, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
Researchers from the University of Michigan and Northwestern University are studying people's experiences with swelling caused by Nephrotic Syndrome. Interviews with patients (child and adult) and parents of young children will be conducted. The information collected from the interviews will be used to develop a survey to use when testing new medications for Nephrotic Syndrome. Please consider participating in a 1-hour long interview with the Prepare-NS research study to discuss children and adults experiences with swelling.
Primary Outcome
Themes generated through qualitative analysis from semi-structured interviews
Conditions Studied
Interventions
- BEHAVIORAL Interview
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2022-04-18 |
| Est. Completion | 2026-04-30 |
What NCT05505500 shows while recruiting
NCT05505500 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 453-participant average among 13 other Edema trials with a reported enrollment target (67% lower).
The record links to 10 conditions, with Edema appearing as the primary indexed condition, and to 1 intervention - of which Interview is the first listed.
NCT05505500 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT05505500 about?
NCT05505500 is a clinical study titled "Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.". Researchers from the University of Michigan and Northwestern University are studying people's experiences with swelling caused by Nephrotic Syndrome. Interviews with patients (child and adult) and parents of young children will be conducted. The information collected from the interviews will be used...
What is the current status of trial NCT05505500?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2022-04-18. Estimated completion is 2026-04-30.
What conditions does trial NCT05505500 study?
This clinical trial studies the following conditions: Edema, Fluid Overload, Nephrotic Syndrome, Minimal Change Disease, Membranous Nephropathy.
What interventions are being tested in trial NCT05505500?
The interventions under investigation include: Interview (BEHAVIORAL).
Who is sponsoring clinical trial NCT05505500?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05505500 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Edema
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05505500's enrollment target sits among peer trials
150 4th of 13 higher than 10 of 13 other Edema trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Edema trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Surgical Evaluation for Upper Extremity Lymphedema (BioBridge)
RECRUITING · NA
-
LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge)
RECRUITING · NA
-
Diuretic Tuner Clinical Decision Support
RECRUITING · NA
-
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
RECRUITING
-
Pembrolizumab in Treating Patients With Stage IV Metastatic or Recurrent Inflammatory Breast Cancer or Triple-Negative Breast Cancer Who Have Achieved Clinical Response or Stable Disease to Prior Chemotherapy
ACTIVE NOT RECRUITING · Phase 2
-
Screening For BCRL In Targeted Therapy For Breast Cancer
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI